Underutilization of Combined-Modality Therapy in Limited-Stage Small Cell Lung Cancer

Sara Alcorn, David B. Miller, Russell Hales

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalJAMA oncology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Combined Modality Therapy
Small Cell Lung Carcinoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Underutilization of Combined-Modality Therapy in Limited-Stage Small Cell Lung Cancer. / Alcorn, Sara; Miller, David B.; Hales, Russell.

In: JAMA oncology, 01.01.2018.

Research output: Contribution to journalArticle

@article{5add507e74e24155868be0cc47143181,
title = "Underutilization of Combined-Modality Therapy in Limited-Stage Small Cell Lung Cancer",
author = "Sara Alcorn and Miller, {David B.} and Russell Hales",
year = "2018",
month = "1",
day = "1",
doi = "10.1001/jamaoncol.2018.3261",
language = "English (US)",
journal = "JAMA oncology",
issn = "2374-2437",
publisher = "American Medical Association",

}

TY - JOUR

T1 - Underutilization of Combined-Modality Therapy in Limited-Stage Small Cell Lung Cancer

AU - Alcorn, Sara

AU - Miller, David B.

AU - Hales, Russell

PY - 2018/1/1

Y1 - 2018/1/1

UR - http://www.scopus.com/inward/record.url?scp=85052708109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052708109&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2018.3261

DO - 10.1001/jamaoncol.2018.3261

M3 - Article

C2 - 30073331

AN - SCOPUS:85052708109

JO - JAMA oncology

JF - JAMA oncology

SN - 2374-2437

ER -